Benicar: Effective Blood Pressure Control for Cardiovascular Health

Benicar

Benicar

Benicar is used to control high blood pressure in adults and children who are at least 6 years old.
Product dosage: 10mg
Package (num) Per pill Price Buy
60 $0.73 $44.00 (0%) 🛒 Add to cart
90 $0.63 $66.00 $57.00 (14%) 🛒 Add to cart
120 $0.57 $88.00 $68.00 (23%) 🛒 Add to cart
180 $0.51 $132.00 $91.00 (31%) 🛒 Add to cart
270 $0.47 $198.00 $126.00 (36%) 🛒 Add to cart
360
$0.45 Best per pill
$264.00 $161.00 (39%) 🛒 Add to cart
Product dosage: 20mg
Package (num) Per pill Price Buy
30 $1.40 $42.00 (0%) 🛒 Add to cart
60 $1.10 $84.00 $66.00 (21%) 🛒 Add to cart
90 $1.01 $126.00 $91.00 (28%) 🛒 Add to cart
120 $0.96 $168.00 $115.00 (32%) 🛒 Add to cart
180 $0.91 $252.00 $164.00 (35%) 🛒 Add to cart
270 $0.88 $378.00 $238.00 (37%) 🛒 Add to cart
360
$0.86 Best per pill
$504.00 $310.00 (38%) 🛒 Add to cart
Product dosage: 40mg
Package (num) Per pill Price Buy
30 $2.73 $82.00 (0%) 🛒 Add to cart
60 $2.18 $164.00 $131.00 (20%) 🛒 Add to cart
90 $2.01 $246.00 $181.00 (26%) 🛒 Add to cart
120 $1.92 $328.00 $230.00 (30%) 🛒 Add to cart
180 $1.83 $492.00 $329.00 (33%) 🛒 Add to cart
270
$1.77 Best per pill
$738.00 $478.00 (35%) 🛒 Add to cart
Synonyms

Benicar (olmesartan medoxomil) is an angiotensin II receptor blocker (ARB) prescription medication specifically formulated for the management of hypertension in adults. It works by selectively blocking the action of angiotensin II, a substance in the body that causes blood vessels to tighten, leading to their relaxation and subsequent lowering of blood pressure. This mechanism provides a modern, targeted approach to hypertension management, helping to reduce the risk of strokes, heart attacks, and kidney problems associated with consistently high blood pressure. Clinical studies support its efficacy as a monotherapy or in combination with other antihypertensive agents, offering a reliable option for long-term cardiovascular health maintenance under medical supervision.

Features

  • Active ingredient: Olmesartan medoxomil
  • Drug class: Angiotensin II receptor blocker (ARB)
  • Available in tablet form for oral administration
  • Standard dosage strengths: 5 mg, 20 mg, 40 mg
  • Designed for once-daily dosing to support patient adherence
  • Bioavailability is not affected by food intake

Benefits

  • Provides consistent 24-hour blood pressure control with a single daily dose.
  • Effectively lowers both systolic and diastolic blood pressure readings.
  • Helps reduce the long-term risk of major cardiovascular events, including stroke and myocardial infarction.
  • Can be used as a standalone therapy or effectively combined with other antihypertensive drugs like diuretics.
  • Generally well-tolerated profile in a majority of the adult patient population.
  • Offers a targeted mechanism of action with a low incidence of certain side effects like cough, which can be associated with other drug classes.

Common use

Benicar is indicated for the treatment of hypertension, more commonly known as high blood pressure, in adult patients. It may be used as the initial drug of choice or as part of a broader antihypertensive regimen when a single agent does not provide adequate control. Its primary role is to manage chronic elevation in blood pressure, a significant modifiable risk factor for atherosclerosis, heart failure, renal impairment, and cerebrovascular accidents. Treatment is typically long-term and must be continuous to maintain therapeutic benefits, as hypertension is a chronic condition requiring ongoing management.

Dosage and direction

The recommended starting dose of Benicar is 20 mg taken orally once daily. Depending on the patient’s blood pressure response, the dosage may be titrated up to a maximum of 40 mg once daily after two weeks if adequate control is not achieved. For patients with possible volume depletion (e.g., those on high-dose diuretics), a lower initial dose of 5 mg may be considered. It can be taken with or without food. Tablets should be swallowed whole with a glass of water. Dosage adjustments for patients with hepatic or severe renal impairment are generally not required, but careful monitoring is advised. The dose for a specific patient must be determined by a healthcare provider based on individual clinical response and tolerability.

Precautions

Patients should be monitored for symptomatic hypotension, especially in volume-depleted patients or those with severe congestive heart failure. Periodic assessment of renal function is recommended, as use of drugs acting on the renin-angiotensin system can cause changes in renal function, including acute renal failure. Care is advised in patients with a history of hepatic impairment. This medication can cause injury and death to a developing fetus; pregnancy must be excluded before starting treatment and avoided during therapy. Patients should be advised to avoid becoming dehydrated, to maintain adequate fluid intake, and to report symptoms such as lightheadedness, especially during the initiation of therapy. Potassium levels should be monitored in patients with impaired renal function and those taking potassium-sparing diuretics or potassium supplements.

Contraindications

Benicar is contraindicated in patients with known hypersensitivity to olmesartan medoxomil or any component of the formulation. Do not co-administer with aliskiren in patients with diabetes. Its use is contraindicated during the second and third trimesters of pregnancy due to the risk of causing fetal harm, including hypotension, neonatal skull hypoplasia, anuria, reversible or irreversible renal failure, and death.

Possible side effect

Like all medicines, Benicar can cause side effects, although not everybody gets them. Common side effects may include dizziness, headache, hypertriglyceridemia, hyperuricemia, upper respiratory tract infection, pharyngitis, rhinitis, sinusitis, diarrhea, and back pain. Less common but more serious side effects can include severe hypotension, impaired renal function (elevated serum creatinine), hyperkalemia (elevated blood potassium), and rare cases of sprue-like enteropathy have been reported, characterized by severe, chronic diarrhea with substantial weight loss. Patients should contact their doctor immediately if they experience symptoms of allergic reaction (e.g., swelling of the face, lips, tongue, or throat, difficulty breathing), fainting, or symptoms suggesting enteropathy.

Drug interaction

Potential drug interactions should be carefully considered. Concomitant use with other blood pressure-lowering agents (e.g., other ARBs, ACE inhibitors, beta-blockers, diuretics) may increase the risk of hypotension. Concurrent use with potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium. NSAIDs (e.g., ibuprofen, naproxen), including selective COX-2 inhibitors, may diminish the antihypertensive effect and increase the risk of renal impairment. The antihypertensive effect may be reduced by coadministration with lithium; increased monitoring of lithium levels is recommended. Avoid use with aliskiren in patients with diabetes.

Missed dose

If a dose of Benicar is missed, it should be taken as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Do not take a double dose to make up for a forgotten one. Maintaining a consistent daily routine is important for optimal blood pressure control.

Overdose

The most likely manifestation of an overdose is hypotension and tachycardia; bradycardia could also occur from vagal stimulation. If overdose occurs, the patient should be placed in a supine position and supportive treatment initiated promptly, including intravenous normal saline to restore volume and pressure. Olmesartan is not removed by hemodialysis. Treatment is symptomatic and supportive, with close monitoring of vital signs and serum electrolytes. Management should be conducted under direct medical supervision.

Storage

Store Benicar tablets at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the medication in its original container, tightly closed, and out of reach of children and pets. Protect from light and moisture. Do not store in the bathroom. Safely discard any medication that is outdated or no longer needed.

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and may not cover all possible uses, directions, precautions, interactions, or adverse effects.

Reviews

  • “As a cardiologist with over 20 years of practice, I find Benicar to be a reliable and effective agent in my arsenal for managing stage 1 and 2 hypertension. Its once-daily dosing promotes excellent patient compliance, and I observe consistent BP-lowering effects in my patient population with a favorable side effect profile compared to some older agents.” – Dr. A. Reynolds, MD
  • “After trying two other medications that caused persistent coughing, my physician switched me to Benicar. My blood pressure has been well-controlled for three years now without that bothersome side effect. It fits easily into my daily routine.” – Patient M., 58
  • “In our clinical practice, we utilize Benicar frequently, particularly for patients who are not adequately controlled on an ACE inhibitor or who cannot tolerate them. It serves as an effective component of combination therapy when needed.” – Clinical Pharmacist, Cardiology Group
  • “I was diagnosed with hypertension last year and was initially very anxious about starting medication. My doctor prescribed Benicar 20mg. The process was straightforward, and my follow-up readings have shown significant improvement. I’ve experienced no notable side effects.” – Patient T., 45
  • “From a formulary management perspective, Benicar offers a strong clinical profile within its class. Its efficacy data is robust, and it remains a cost-effective option for many of our plan members requiring ARB therapy.” – P&T Committee Member, Health Plan